ArticleOpen forum infectious diseases2015

Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.

Saran Vardhanabhuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.